These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13738700)

  • 21. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
    White BN; Cox AC; Taylor FB
    J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative relationship between clotting factors V and VII in prothrombin conversion].
    WITTE S; DIRNBERGER P
    Acta Haematol; 1953 Jun; 9(6):380-8. PubMed ID: 13079572
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.
    INNES D; SEVITT S
    J Clin Pathol; 1964 Jan; 17(1):1-13. PubMed ID: 14103515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of thrombin in clotting blood by radioimmunoassay.
    Shuman MA; Majerus PW
    J Clin Invest; 1976 Nov; 58(5):1249-58. PubMed ID: 993343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of heparin on the early stages of blood coagulation.
    O'BRIEN JR
    J Clin Pathol; 1960 Mar; 13(2):93-8. PubMed ID: 14428016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-decalcified barium sulfate-adsorbed plasma. A potentially useful reagent for studying blood clotting, platelets or complement.
    Zucker MB; Owen J
    Thromb Haemost; 1982 Apr; 47(2):182-4. PubMed ID: 6808695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The concentration of the labile factor of the prothrombin complex in human, dog, and rabbit blood; its significance in the determination of prothrombin activity.
    QUICK AJ; STEFANINI M
    J Lab Clin Med; 1948 Jul; 33(7):819-26. PubMed ID: 18869568
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adsorption properties of Beidellite (author's transl)].
    Soulier JP; Prou-Wartelle O; Halle L
    Nouv Rev Fr Hematol; 1975; 15(2):183-93. PubMed ID: 241060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methodological improvements in the determination of the labile factor].
    TURPINI R
    Boll Soc Ital Biol Sper; 1956; 32(1-2):148-51. PubMed ID: 13374062
    [No Abstract]   [Full Text] [Related]  

  • 31. The concentration of the labile factor of prothrombin in the blood of various species.
    STEFANINI M; QUICK AJ
    Fed Proc; 1948 Mar; 7(1 Pt 1):191. PubMed ID: 18938817
    [No Abstract]   [Full Text] [Related]  

  • 32. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
    Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human prothrombin; quantitative studies on the plasma labile factor and the restorative effects of normal, hypofibrinogenemic, and hemophilic plasma on the prothrombin of stored plasma.
    ALEXANDER B; DE VRIES A
    J Clin Invest; 1949 Jan; 28(1):24-31. PubMed ID: 18107517
    [No Abstract]   [Full Text] [Related]  

  • 37. The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.
    ALEXANDER B; GOLDSTEIN R; LANDWEHR G
    J Clin Invest; 1951 Mar; 30(3):252-62. PubMed ID: 14824275
    [No Abstract]   [Full Text] [Related]  

  • 38. Kallikrein activates prothrombin.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 40. On the clot-promoting activity of human platelets in a one-stage prothrombinase assay.
    Bevers EM; Comfurius P; Hemker HC; Zwaal RF
    Haemostasis; 1982; 12(3):268-74. PubMed ID: 7141305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.